334 related articles for article (PubMed ID: 24283110)
21. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
22. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
23. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
[TBL] [Abstract][Full Text] [Related]
24. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
Ozhan H; Erden I; Ordu S; Aydin M; Caglar O; Basar C; Yalcin S; Alemdar R
Angiology; 2010 Oct; 61(7):711-4. PubMed ID: 20395226
[TBL] [Abstract][Full Text] [Related]
26. Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
Insull W; Ghali JK; Hassman DR; Y As JW; Gandhi SK; Miller E;
Mayo Clin Proc; 2007 May; 82(5):543-50. PubMed ID: 17493418
[TBL] [Abstract][Full Text] [Related]
27. Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
Tsutamoto T; Sakai H; Ibe K; Yamaji M; Kawahara C; Nakae I; Fujii M; Yamamoto T; Horie M
Circ J; 2011; 75(9):2160-6. PubMed ID: 21737951
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).
Ko YG; Won H; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Bae JH; Lee S; Lim DS; Jang Y
Am J Cardiol; 2014 Jul; 114(1):29-35. PubMed ID: 24831577
[TBL] [Abstract][Full Text] [Related]
30. High-dose atorvastatin for preventing contrast-induced nephropathy in primary percutaneous coronary intervention.
Jo SH; Hahn JY; Lee SY; Kim HJ; Song YB; Choi JH; Choi SH; Lee SH; Gwon HC
J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):213-9. PubMed ID: 25032713
[TBL] [Abstract][Full Text] [Related]
31. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
[No Abstract] [Full Text] [Related]
32. Rosuvastatin-induced arrest in progression of renal disease.
Vidt DG; Cressman MD; Harris S; Pears JS; Hutchinson HG
Cardiology; 2004; 102(1):52-60. PubMed ID: 15073451
[TBL] [Abstract][Full Text] [Related]
33. Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).
Pitt B; Loscalzo J; Monyak J; Miller E; Raichlen J
Am J Cardiol; 2012 May; 109(9):1239-46. PubMed ID: 22360820
[TBL] [Abstract][Full Text] [Related]
34. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
[TBL] [Abstract][Full Text] [Related]
35. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
36. [Atorvastatin prevents contrast agent-induced renal injury in patients undergoing coronary angiography by inhibiting oxidative stress].
Cao S; Wang P; Cui K; Zhang L; Hou Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1600-2. PubMed ID: 23174584
[TBL] [Abstract][Full Text] [Related]
37. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Kurtul A; Duran M
Clin Cardiol; 2017 Apr; 40(4):235-242. PubMed ID: 28244599
[TBL] [Abstract][Full Text] [Related]
38. Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography.
Acikel S; Muderrisoglu H; Yildirir A; Aydinalp A; Sade E; Bayraktar N; Bal U; Ozin B
Blood Coagul Fibrinolysis; 2010 Dec; 21(8):750-7. PubMed ID: 20962623
[TBL] [Abstract][Full Text] [Related]
39. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
[TBL] [Abstract][Full Text] [Related]
40. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
